Related Experiment Video
Updated: May 24, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
[Diabetes in Mexico. CARMELA study]
Jorge Escobedo-de la Peña1, Luisa Virginia Buitrón-Granados, Jesús Cenobio Ramírez-Martínez
1Unidad de Investigación en Epidemiología Clínica, Hospital Regional, Instituto Mexicano del Seguro Social, México, D. F., Mexico. jorgeep@unam.mx
Cirugia Y Cirujanos
|March 6, 2012
Summary
Type 2 diabetes is highly prevalent in Mexico City, affecting 9.7% of women and 8.0% of men. Key risk factors include age, obesity, and hypertension, highlighting the need for targeted health policies.
Area of Science:
- Endocrinology
- Public Health
- Cardiology
Background:
- Diabetes mellitus presents epidemic levels in Mexico, a country with a high diabetes patient population.
- Understanding the prevalence and associated risk factors for type 2 diabetes is crucial for public health initiatives.
Purpose of the Study:
- To estimate the prevalence of type 2 diabetes in Mexico City.
- To investigate the relationship between type 2 diabetes and cardiovascular risk factors.
Main Methods:
- A cross-sectional study involved 1,772 randomly selected adults aged 25–64.
- Prevalence of type 2 diabetes and impaired fasting glucose was assessed.
- Cardiovascular risk factors including hypertension, dyslipidemia, obesity, abdominal obesity, and carotid intima-media thickness were evaluated.
Main Results:
- Type 2 diabetes prevalence was 9.7% in women and 8.0% in men, with a notable age effect.
- 26% of individuals with diabetes were unaware of their condition.
- Significant risk factors identified were age, abdominal obesity, hypertension, low HDL-c, and hypertriglyceridemia; metabolic control was poor.
Conclusions:
- The high prevalence of type 2 diabetes in Mexico underscores its status as a major health concern.
- The strong association with cardiovascular risk factors necessitates public health policies focused on risk factor reduction.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...